Marcucci et al. [45] reported hot spots mutations for IDH1 (R132) and IDH2 (R140 and R172), occurring in approximately 8% and 12% of patients with cytogenetically normal AML. This evidence concerns the gene IDH2 and acute myeloid leukemia.